1.0CureVachttps://www.curevac.com/en/CureVac Announces Full Exercise of Underwriters’ Option to Purchase Additional Common Sharesrich600338<blockquote class="wp-embedded-content" data-secret="B5nUgcNUyH"><a href="https://www.curevac.com/en/curevac-announces-full-exercise-of-underwriters-option-to-purchase-additional-common-shares/">CureVac Announces Full Exercise of Underwriters’ Option to Purchase Additional Common Shares</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.curevac.com/en/curevac-announces-full-exercise-of-underwriters-option-to-purchase-additional-common-shares/embed/#?secret=B5nUgcNUyH" width="600" height="338" title="“CureVac Announces Full Exercise of Underwriters’ Option to Purchase Additional Common Shares” — CureVac" data-secret="B5nUgcNUyH" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
CureVac N.V. (Nasdaq: CVAC) (“CureVac” or the “Company”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced today that the underwriters of its previously announced public offering, which closed on February 1, 2021, have exercised in full their option to purchase an additional 750,000 of its common shares at the public offering price of $90.00 per common share, less underwriting discounts and commissions.https://www.curevac.com/wp-content/uploads/2021/02/CureVac-Logo-Social.png1200630